Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Trying to decide which is better: cash back or points credit cards? Analyze your spending habits to make the best choice for maximizing rewards.
27,088 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
A tight group of U.S.-listed power chip stocks built around silicon carbide and GaN technologies are rallying as elec...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
A Friday deadline intensifies a clash between Anthropic and the Pentagon over how its Claude AI models may be used by...
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
XRP is testing critical levels near $1.40 this week as traders watch for a breakout. Momentum is building, but regula...
Equities drift lower while major crypto assets flicker between resistance and support. ETH struggles near a key ceili...
Pope Leo XIV issues Magnifica Humanitas, framing AI as a modern social contract test that echoes the Industrial Revol...
Trading activity in the largest non-stablecoin crypto assets cooled to two-year lows as investors sit on the sideline...